Clinical Trial Update: A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating MRG006A in patients with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MRG006A

Snippet

Sponsor: Lepu Biopharma Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING